Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Procyon and Biovation enter cancer immunotherapy agreement

Oct. 13, 2000

Antitumor agents patented by Japanese researchers

Oct. 11, 2000

Recent patent covers new inhibitors of specific MMPs

Oct. 11, 2000

Novel target for anticancer therapy and new compounds discovered at Klinge

Oct. 10, 2000

CRL-8256, with potential in cancer chemotherapy, emerges from joint French and Belgian research

Oct. 10, 2000

Coulter's Bexxar assigned priority review status by FDA

Oct. 10, 2000

Myriad reports location of prostate cancer susceptibility gene

Oct. 10, 2000

Clinical trial results for IL-2/SEB combination therapy for melanoma positive

Oct. 10, 2000

Potent topoisomerase inhibitors related to camptothecin described in recent patent

Oct. 6, 2000

Dihydroquinazoline antitumor agents with folate-independent mechanism described by CRC

Oct. 6, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
Anle-138b reduces mHTT aggregation, improves pathological phenotypes in Huntington’s models
BioWorld Science
Anle-138b (emrusolmin) is a diphenylpyrazole compound that directly interacts with oligomeric species of disease-related aggregating proteins, reducing aggregate...